Pharmapack’s Post

#XELUM is the key technology when it comes to #simplicity, #flexibility, #efficiency, #cleanability without the negative side effects in regard to scale-up efforts and product losses. Excerpt of the conclusions chapter in the article below: "7. Conclusion  In the current business environment that emphasizes reducing the  time to market in a cost-effective manner, it is necessary to look for  faster and innovative ways of conducting drug product process devel- opment while ensuring product quality. The development studies should  leverage existing literature information and follow a risk-based  approach to prioritize investigating the main variables/effects that are  important to develop a robust process. 

Whitehead Scientific & SPT Labtech Laboratories are increasingly transitioning from manual pipetting to automated liquid handling, to drive efficiency and meet the throughput demands of modern research. Automating these repetitive and menial tasks boosts productivity and improves data quality by minimizing the risk of human error. Bringing together individual processes into a flexible and scalable workflow allows you to take a step further, to maximize walkaway time while aligning with your unique needs – whether you’re a budding biotech startup or an enterprise-level pharmaceutical organization. You can now access the SPT Labtech webinar recording where they'll explore the business benefits of combining these powerful technologies before taking a deeper dive into the practical considerations to follow ➡️ https://lnkd.in/dqa5KKSX 🛒 Visit our webshop and unlock a world of possibilities ➡️ https://lnkd.in/eeMEMUTe Contact us today at whitesci@whitesci.co.za to talk to a specialist #whiteheadscientific #labequipment #webinar #science #biotech

Laboratories are increasingly transitioning from manual pipetting to automated liquid handling, to drive efficiency and meet the throughput demands of modern research. Automating these repetitive and menial tasks boosts productivity and improves data quality by minimizing the risk of human error.  Bringing together individual processes into a flexible and scalable workflow allows you to take a step further, to maximize walkaway time while aligning with your unique needs – whether you’re a budding biotech startup or an enterprise-level pharmaceutical organization.  You can now access the SPT Labtech webinar recording where they'll explore the business benefits of combining these powerful technologies before taking a deeper dive into the practical considerations to follow ➡️ https://lnkd.in/dqa5KKSX 🛒 Visit our webshop and unlock a world of possibilities ➡️ https://lnkd.in/eeMEMUTe Contact us today at whitesci@whitesci.co.za to talk to a specialist #whiteheadscientific #labequipment #webinar #science #biotech

Automation is redefining the pharmaceutical landscape, driving unparalleled efficiency and precision. By leveraging Process Analytical Technology (PAT) for in-depth process optimization and data analytics, a leap towards smarter manufacturing processes is being witnessed. The shift towards modular systems marks a new era of connectivity, where seamless integration of sensors and equipment accelerates innovation in drug development and production. Standing on the brink of this automation revolution, the potential for enhancing product quality and fostering sustainable practices has never been greater. The future of pharmaceuticals is not just automated—it's intelligent, adaptive, and sustainable. #Pharma #Automation #Sustainability

#Packaging #solutions provider, SGD Pharma, is opening a new #siliconisation operation at its Saint-Quentin Lamotte (SQLM) plant. Find out more on Scientist Live - https://loom.ly/ck_qjVw Subscribe to our newsletter here - https://loom.ly/km0X6OM #science #sciencenews #scientificresearch

ARTICLE – #Pharma innovators are using technology to meet today’s market demands. Emerson’s Director of Life Sciences Strategy, Michalle Adkins shared in her article in Pharma Manufacturing how to navigate the smaller batch market. She shared that today’s therapies are sophisticated and more targeted and require smaller batch sizes to meet targeted therapies. Read the full article. https://ow.ly/2etf30sACo3 #software #analytics

At Constructive Bio, we're not just engineering the future of biomanufacturing; we're reinventing it. Our groundbreaking approach transcends traditional bioprocessing, unlocking the full potential of complex biomolecules. This is where programmable GLP-1 agonists and vaccines meet personalized healthcare needs, marking a leap into a future driven by precision and adaptability. Our ambition is bold: to fundamentally reshape the landscape of biomanufacturing. We're not just refining existing systems; we're envisioning and constructing sustainable, green cellular biofactories from scratch. These factories deliver programmable molecules with exotic chemistries, meticulously crafted, delivered, and evaluated for unparalleled efficacy due to the unprecedented composition. We're redefining the blueprints of ribosome-produced molecules and the biofactories that craft them, integrating previously untapped chemistries and ensuring a harmonious, innovative fusion of technology and biology. The shift is monumental. We're leaving behind the outdated confines of heritage chemistry and the inefficiencies that have long plagued biomanufacturing. The future we envision is free from the constraints of stochastic strain delivery, purity complications, and laborious, multi-step manufacturing processes. We're setting a new standard, replacing ad-hoc, project-based engineering with a streamlined, scalable, and highly adaptable production paradigm. This isn't just a narrative of "advanced manufacturing" or "biomanufacturing play"; it's a commitment to health, hope, and a future where life-saving treatments are universally accessible: that requires right molecules and right supply chain. The most effective drugs won't benefit millions if they cannot be produced. At Constructive Bio we're not "just" making biology programmable. This is followed by ensuring that these revolutionary processes are scalable by design, setting a new industry standard. With genetic code expansion already charting a new course, Constructive Bio stands at the forefront, bringing an unprecedented level of choice, flexibility, and sophistication to the biologics. Our pipeline isn't, however, just about introducing new chemistries; it's about rewriting the rulebook of what's possible in programmable biomolecules. Both outsourcing and building internal capacity can be effective long term strategies, provided that the processes are robust and transferable, rather than being the 'one-trick pony' bioprocesses of the past. https://lnkd.in/erKgiREc

#Packaging #solutions provider, SGD Pharma, is opening a new #siliconisation operation at its Saint-Quentin Lamotte (SQLM) plant. Find out more on Scientist Live - https://loom.ly/ck_qjVw Subscribe to our newsletter here - https://loom.ly/km0X6OM #science #sciencenews #scientificresearch

ARTICLE – #Pharma innovators are using technology to meet today’s market demands. Emerson’s Director of Life Sciences Strategy, Michalle Adkins shared in her article in Pharma Manufacturing how to navigate the smaller batch market. She shared that today’s therapies are sophisticated and more targeted and require smaller batch sizes to meet targeted therapies. Read the full article. http://emr.as/9aYK50QMtN0 #software #analytics

ARTICLE – #Pharma innovators are using technology to meet today’s market demands. Emerson’s Director of Life Sciences Strategy, Michalle Adkins shared in her article in Pharma Manufacturing how to navigate the smaller batch market. She shared that today’s therapies are sophisticated and more targeted and require smaller batch sizes to meet targeted therapies. Read the full article. http://emr.as/9aYK50QMtN0 #software #analytics